EMPIGET-M 5/500 EMPAGLIFLOZIN 5MG/METFORMIN 500MG 28’S

Empiget-M 5/500 is a combination medication containing Empagliflozin 5mg and Metformin 500mg, primarily used for the management of type 2 diabetes mellitus. This drug works by improving glycemic control in adults with diabetes, helping to lower blood sugar levels effectively. Empagliflozin, an SGLT2 inhibitor, reduces glucose reabsorption in the kidneys, promoting its excretion through urine, while Metformin enhances insulin sensitivity and decreases hepatic glucose production.

In Kenya, Empiget-M is commonly prescribed to patients who require additional glycemic control when diet and exercise alone are insufficient. It is particularly beneficial for overweight individuals with type 2 diabetes, as it may also aid in weight loss. Regular use of Empiget-M can help prevent diabetes-related complications, making it a vital part of diabetes management. Always consult a healthcare professional before starting any medication.